NCT01520311View on ClinicalTrials.gov

The eSVS® Mesh Post-Marketing Trial

NATerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Coronary Artery DiseaseMyocardial IschemiaCoronary DiseaseHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases
Interventions
DEVICE

eSVS Mesh

Patients with multi-vessel coronary artery disease who require SVG CABG of the Right Coronary Artery and the Circumflex Artery due to atherosclerotic Coronary Artery Disease will serve as their own control. They will be randomized to either an SVG+eSVS Mesh to the RCA and an SVG to the Cx or an SVG to the RCA and an SVG+eSVS Mesh to the Cx.

Trial Locations (1)

CH-4031

University Hospital, Basel

Sponsors
All Listed Sponsors
collaborator

University Hospital, Basel, Switzerland

OTHER

lead

Kips Bay Medical, Inc.

INDUSTRY